Nurses outperform doctors in colorectal cancer surveillance model

June 12, 2018, The Lead Australia

Putting nurses in charge of colorectal cancer surveillance instead of doctors has shown to reduce the number of unnecessary colonoscopies and the number of cases progressing to cancer.

The South Australian audit of 732 colonoscopies over three months in 2015 found that 97 per cent of procedures adhered to Australian guidelines in the nurse-led model while compliance was just 83 per cent physician-led model.

Led by Flinders Medical Centre Senior Research Scientist Dr. Erin Symonds, the research has been published in the Medical Journal of Australia.

Colorectal cancer (CRC) is one of the world's most prevalent cancers. Early diagnosis has a major impact on survival and can be achieved by screening with faecal occult blood tests (FOBT) or colonoscopy.

Performing colonoscopies too frequently increases costs and the risk of complications, but delays can increase the risk of CRC.

"A family history of CRC or a personal history of adenoma can increase a person's risk of CRC as much as fourfold, and such individuals are advised to undergo regular surveillance colonoscopy," Dr. Symonds and colleagues based at the based at the Flinders Centre for Innovation in Cancer wrote.

"Screening and surveillance guidelines aim to optimise the effectiveness of CRC prevention, with surveillance intervals generally ranging between one and five years."

"Compliance with those recommendations is poor, however, with as many as 89 per cent of patients receiving inappropriate surveillance, usually a colonoscopy before the recommended date."

Based in the South Australian capital of Adelaide, the Southern Co-operative Program for the Prevention of Colorectal Cancer (SCOOP) was established in 1999 to improve surveillance rates to match the Australian National Health and Medical Research Council (NHMRC) guidelines on CRC prevention.

SCOOP was expanded to use two models: one nurse-led in public academic hospitals, where nurses make recommendations based on NHMRC guidelines, which are then confirmed by a physician; and the other, physician-led in private non-academic hospitals where the specialist physician manages the entire process.

Following the introduction of the nurse-led model in 2000, adherence to guidelines increased from 46 per cent to 96 per cent within two years and has since been maintained, demonstrating the long-term sustainability of the model.

In the latest research, the nurse-led model of colorectal cancer surveillance improved compliance with guideline recommendations, reduced the number of unnecessary colonoscopies and reduced the number of cases progressing to cancer by a significant number when compared to the physician-led model.

"Having a process in place that allows for long-term compliance with surveillance guidelines will promote optimal health care, as procedures performed too frequently can increase risks to patients, are expensive, and lengthen waiting lists," Dr. Symonds and colleagues wrote.

"Continuous monitoring of and education about colonoscopy surveillance intervals for patients at elevated risk of CRC promotes adherence to recall guidelines and efficient use of limited endoscopy resources."

Dr. Symonds and her colleagues concluded that the nurse-led for decisions about colorectal surveillance intervals achieves a high degree of compliance with guideline recommendations, which should relieve burdening of colonoscopy resources.

Explore further: Adding surveillance to FIT screening cuts CRC mortality

Related Stories

Adding surveillance to FIT screening cuts CRC mortality

October 3, 2017
(HealthDay)—Adding surveillance to fecal immunochemical test (FIT) screening reduces colorectal cancer (CRC) mortality and increases colonoscopy demand, according to a study published online Oct. 2 in the Annals of Internal ...

Screening for colorectal cancer in under-55-year-olds with family history—benefit unclear

May 30, 2018
Between the age of 50 and 54 years, all statutory health insurance fund members in Germany are entitled to immunological faecal occult blood testing and, in the case of a suspicious result, to a colonoscopy. From the age ...

Overuse of surveillance colonoscopy after resection

February 1, 2013
(HealthDay)—Approximately one-third of patients with normal results on their first and second colonoscopies after undergoing curative resection for colorectal cancer undergo subsequent surveillance colonoscopies within ...

Colorectal cancer patients need colonoscopy after cancer resection

February 16, 2016
It is critically important that colorectal cancer patients undergo colonoscopy after surgery to ensure that they do not have a second colon cancer, and to find and remove any additional polyps. According to new recommendations ...

Follow-up colonoscopies associated with a significantly lower incidence of bowel cancer

April 27, 2017
Patients at risk of developing bowel cancer can significantly benefit from a follow-up colonoscopy, finds research published today in Lancet Oncology.

Recommended for you

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Genomics offers new treatment options for infants with range of soft tissue tumors

June 18, 2018
The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators. Whole genome sequencing of tumours revealed ...

Researchers create novel combination as potential therapy for high-risk neuroblastoma

June 18, 2018
Researchers at VCU Massey Cancer Center in Richmond, Virginia, have identified a promising target to reverse the development of high-risk neuroblastoma and potentially inform the creation of novel combination therapies for ...

Standard myelofibrosis drug can awaken 'dormant' lymphoma

June 18, 2018
Most patients with myelofibrosis, a rare chronic disorder of the haematopoietic cells of the bone marrow, benefit from drugs from the JAK2 inhibitor class: symptoms are relieved, survival extended and general quality-of-life ...

Breast cancer researcher warns against online genetic tests

June 18, 2018
We have never been so fascinated by the secrets inside our cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.